Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.

Bauckneht M, Capitanio S, Donegani MI, Zanardi E, Miceli A, Murialdo R, Raffa S, Tomasello L, Vitti M, Cavo A, Catalano F, Mencoboni M, Ceppi M, Marini C, Fornarini G, Boccardo F, Sambuceti G, Morbelli S.

Cancers (Basel). 2019 Dec 20;12(1). pii: E31. doi: 10.3390/cancers12010031.

2.

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer.

Cattrini C, Castro E, Lozano R, Zanardi E, Rubagotti A, Boccardo F, Olmos D.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1355. doi: 10.3390/cancers11091355. Review.

3.

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients.

Cattrini C, Rubagotti A, Zinoli L, Cerbone L, Zanardi E, Capaia M, Barboro P, Boccardo F.

Cancers (Basel). 2019 Sep 13;11(9). pii: E1365. doi: 10.3390/cancers11091365.

4.

Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience.

Vallome G, Cattrini C, Messina C, Cerbone L, Boccardo F, Zanardi E.

Anticancer Drugs. 2019 Sep;30(8):854-858. doi: 10.1097/CAD.0000000000000805.

PMID:
31356228
5.

To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone.

Zanardi E, Soldato D, Latocca MM, Cattrini C, Boccardo F.

Ther Adv Urol. 2019 Jun 11;11:1756287219854908. doi: 10.1177/1756287219854908. eCollection 2019 Jan-Dec.

6.

Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.

Cattrini C, Cerbone L, Rubagotti A, Zinoli L, Latocca MM, Messina C, Zanardi E, Boccardo F.

Clin Genitourin Cancer. 2019 Aug;17(4):e724-e732. doi: 10.1016/j.clgc.2019.03.010. Epub 2019 Mar 28.

PMID:
31160193
7.

Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.

Cattrini C, Rubagotti A, Nuzzo PV, Zinoli L, Salvi S, Boccardo S, Perachino M, Cerbone L, Vallome G, Latocca MM, Zanardi E, Boccardo F.

Clin Genitourin Cancer. 2018 Dec;16(6):e1257-e1265. doi: 10.1016/j.clgc.2018.07.019. Epub 2018 Jul 29.

PMID:
30170989
8.

CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials.

Messina C, Cattrini C, Buzzatti G, Cerbone L, Zanardi E, Messina M, Boccardo F.

Breast Cancer Res Treat. 2018 Nov;172(1):9-21. doi: 10.1007/s10549-018-4901-0. Epub 2018 Jul 27.

PMID:
30054831
9.

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.

Lambertini M, Fontana V, Massarotti C, Poggio F, Dellepiane C, Iacono G, Abate A, Miglietta L, Ferreccio C, Pescio MC, Conte B, Blondeaux E, Bighin C, D'Alonzo A, Vaglica M, Zanardi E, Boccardo F, Ballestrero A, Anserini P, Del Mastro L.

Breast. 2018 Oct;41:51-56. doi: 10.1016/j.breast.2018.06.012. Epub 2018 Jun 22.

PMID:
30007268
10.

Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer.

Cattrini C, Zanardi E, Boccardo F.

J Clin Oncol. 2018 Aug 1;36(22):2350. doi: 10.1200/JCO.2018.78.0031. Epub 2018 Jun 1. No abstract available.

PMID:
29856689
11.

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.

Cavo A, Rubagotti A, Zanardi E, Fabbroni C, Zinoli L, Di Meglio A, Arboscello E, Bellodi A, Spallarossa P, Cattrini C, Messina C, Boccardo F.

Ther Adv Med Oncol. 2018 Jan 9;10:1758834017745819. doi: 10.1177/1758834017745819. eCollection 2018.

12.

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.

Martel S, Poletto E, Ferreira AR, Lambertini M, Sottotetti F, Bertolini I, Montemurro F, Bernardo A, Risi E, Zanardi E, Ziliani S, Mura S, Dellepiane C, Del Mastro L, Minisini AM, Puglisi F.

Breast. 2018 Feb;37:142-147. doi: 10.1016/j.breast.2017.11.004. Epub 2017 Nov 21.

PMID:
29161652
13.

May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials.

Messina C, Zanardi E, Boccardo F.

Anticancer Agents Med Chem. 2017;17(12):1633-1643. doi: 10.2174/1871520617666170213114512. Review.

PMID:
28270065
14.

HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature.

Gevorgyan A, Bregni G, Galli G, Zanardi E, de Braud F, Di Cosimo S.

Breast Care (Basel). 2016 Dec;11(6):424-426. doi: 10.1159/000453572. Epub 2016 Dec 9.

15.

Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.

Diminutto A, Basso U, Maruzzo M, Morelli F, De Giorgi U, Perin A, Fraccon AP, Lo Re G, Rizzi A, Sava T, Fornarini G, Valcamonico F, Zustovich F, Massari F, Zanardi E, Roma A, Zattoni F, Zagonel V.

Clin Genitourin Cancer. 2016 Apr;14(2):e161-9. doi: 10.1016/j.clgc.2015.12.009. Epub 2015 Dec 17.

PMID:
26775721
16.

Treatment of elderly patients with metastatic renal cell carcinoma.

Zanardi E, Grassi P, Cavo A, Verzoni E, Maggi C, De Braud F, Boccardo F, Procopio G.

Expert Rev Anticancer Ther. 2016;16(3):323-34. doi: 10.1586/14737140.2016.1131613. Epub 2016 Jan 20. Review.

PMID:
26654225
17.

A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.

Messina C, Zanardi E, Dellepiane C, Tomasello L, Colecchia M, Ravetti GL, Boccardo F, Spina B.

Clin Genitourin Cancer. 2016 Feb;14(1):e139-42. doi: 10.1016/j.clgc.2015.10.012. Epub 2015 Oct 28. Review. No abstract available.

PMID:
26627132
18.

Better Together: Targeted Combination Therapies in Breast Cancer.

Zanardi E, Bregni G, de Braud F, Di Cosimo S.

Semin Oncol. 2015 Dec;42(6):887-95. doi: 10.1053/j.seminoncol.2015.09.029. Epub 2015 Sep 24. Review.

PMID:
26615133
19.

Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa).

Nuzzo PV, Rubagotti A, Argellati F, Di Meglio A, Zanardi E, Zinoli L, Comite P, Mussap M, Boccardo F.

Int J Mol Sci. 2015 Jul 28;16(8):17181-92. doi: 10.3390/ijms160817181.

20.

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma.

Zanardi E, Verzoni E, Grassi P, Necchi A, Giannatempo P, Raggi D, De Braud F, Procopio G.

Ther Adv Urol. 2015 Jun;7(3):152-61. doi: 10.1177/1756287215574457. Review.

Supplemental Content

Loading ...
Support Center